In short. The classic early pair in a vascular occlusion, why both are easy to explain away, how quickly they declare themselves, and when they mean emergency care.
Key points
- Blanching and disproportionate pain are not a checklist to be completed.
- Either one on its own is enough to make the call.
- A patient with severe pain and normal-looking skin, and a patient with a pale patch and little pain, are both having the same emergency until someone qualified says otherwise.
Most vascular occlusions announce themselves with one of two findings, and often with both. The skin over or near the treated area turns white or pale and does not refill when pressed, and the pain is far greater than the injection should explain and keeps climbing rather than settling. Neither is subtle once it is recognised. Both are easy to explain away, which is why they are worth learning before there is any reason to use them.
Blanching, and what it is not
Blanching is skin that has lost its blood supply, and it behaves differently from the pallor that follows an injection. It is an area that has gone white, grey or dusky, whose edges may be mottled or show a fine net-like pattern, and which does not pink up when it is pressed and released. It often feels cool to the touch compared with the skin alongside it. It does not fade over the next ten minutes while you watch it, and it does not improve when the swelling settles. Because a treated area is often a little pale from the product and the local anaesthetic, the distinguishing feature is persistence rather than appearance at any one moment.
Two signs, one decision
Blanching and disproportionate pain are not a checklist to be completed. Either one on its own is enough to make the call. A patient with severe pain and normal-looking skin, and a patient with a pale patch and little pain, are both having the same emergency until someone qualified says otherwise.
Pain that is out of proportion
An injection aches. That ache is worst at the moment of injection, it is dull rather than sharp, and it improves over the hours that follow. Pain that is out of proportion is different in kind: it is severe enough to dominate what you are thinking about, it may be sharp or burning, it is often felt in a distribution that does not match where the needle went, and its direction is upwards. Patients frequently describe it as the worst pain they have had in the face, and quite often they describe it as unlike anything they expected from an injection. The direction of travel matters more than the number anyone would put on it.
How quickly they declare themselves
Both findings typically appear within minutes to a few hours of the injection, and they progress. Blanching may begin as a small patch and extend; pain may begin as an ache and become something else. That progression is the reason the response is immediate rather than observational. An ordinary reaction is at its worst early and then improves. An occlusion does the opposite, and the difference between those two directions is what a patient is best placed to notice.
Seek emergency care now if
- Skin has turned white, grey, mottled or dusky, or shows a lacy pattern, or feels cold.
- Pain is severe, out of proportion to the injection, or worsening rather than easing.
- Either of the above is present together with any change in vision or a drooping eyelid.
The value of learning these two signs is not diagnostic. It is that they turn a vague worry into a sentence that can be said out loud on the telephone, and that sentence is what starts an assessment.
Frequently asked questions
What does blanching after filler look like?
An area of skin that has gone white or pale, does not pink up again when it is pressed and released, and may look mottled around its edges. It is different from the swelling or the slight paleness that follows an injection, because it persists and it does not refill. A cold feel to the same area belongs with it.
How much pain is too much after a filler injection?
Pain that is out of proportion to what was done, and pain that keeps worsening instead of easing, are both too much. An ordinary injection ache is worst at the start and settles. Pain that is severe enough to dominate your attention, or that is climbing hour by hour, is a finding rather than a symptom.
Can an occlusion happen with only one of the two signs?
Yes, and either one alone is enough to act on. Blanching without much pain, and severe pain without obvious blanching, both occur, and both are treated the same way. Waiting for both to be present before seeking care is the mistake this pairing is most likely to cause.
Risks & Limitations
- The site of the injection is not the site of the damage: filler that enters an artery is carried by the blood flow and lodges downstream.
- Only a filler of the enzyme-dissolvable class can be dissolved. Biostimulators, polycaprolactone and calcium-based fillers cannot.
- Dissolving the product removes the cause; it does not repair tissue that has already lost its blood supply.
- The glabella, nose, forehead, temple and tear trough share a blood supply with the eye, which is why they are treated with particular care.
- A change in vision after a facial injection is an emergency in which minutes matter, and recovery cannot be assumed.
- Where skin or vision has been lost, later treatment can improve an area but does not restore what was there before.
When to Seek Care
- Severe pain out of proportion to the injection, or pain that keeps worsening — seek emergency care now.
- Skin turning white, grey, mottled or dusky, a lacy or blotchy pattern, or skin that feels cold — seek emergency care now.
- Any change in vision, a drooping eyelid, or pain and swelling around the eye — seek emergency care now; minutes matter.
- Blistering, peeling or darkening skin over a treated area — seek emergency care now.
- A severe headache, or weakness or numbness on one side of the body — seek emergency care now and call emergency services.
- A reaction that is not settling but is not in this list — contact your treating team the same day.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — injectable filler safety guidance
- U.S. Food and Drug Administration (FDA) — dermal filler safety information
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.